PND55 - A COST-EFFECTIVENESS ANALYSIS USING REAL-WORLD DATA...

PND55 - A COST-EFFECTIVENESS ANALYSIS USING REAL-WORLD DATA FROM THE MSBASE REGISTRY: COMPARING NATALIZUMAB TO FINGOLIMOD IN PATIENTS WITH INADEQUATE RESPONSE TO DISEASE-MODIFYING THERAPIES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY

Herring, W, Gould, IG, Casamassima, G, Dort, T, Zhang, Y, Acosta, C, Hyde, R, Spelman, T, Butzkueven, H
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.2021
Date:
October, 2018
File:
PDF, 374 KB
english, 2018
Conversion to is in progress
Conversion to is failed